{{ currentBoardShortName }}
  • Markets
  • Indices
  • Currencies
  • Energy
  • Metals
Markets
As of: {{timeStamp.date}}
{{timeStamp.time}}

Markets

{{ currentBoardShortName }}
  • Markets
  • Indices
  • Currencies
  • Energy
  • Metals
{{data.symbol | reutersRICLabelFormat:group.RICS}}
 
{{data.netChng | number: 4 }}
{{data.netChng | number: 2 }}
{{data | displayCurrencySymbol}} {{data.price | number: 4 }}
{{data.price | number: 2 }}
{{data.symbol | reutersRICLabelFormat:group.RICS}}
 
{{data.netChng | number: 4 }}
{{data.netChng | number: 2 }}
{{data | displayCurrencySymbol}} {{data.price | number: 4 }}
{{data.price | number: 2 }}

Commodities Videos

VIDEO SIGN OUT

{{ currentStream.Name }}

{{ currentStream.Desc }}

Related Video

Continuous Play:
ON OFF

The information you requested is not available at this time, please check back again soon.

Nov 17, 2016

Canopy Growth halted five times as Canadian marijuana stocks go on wild ride

Employee at the Canopy Growth facility in Smith Falls, Ontario

Security Not Found

The stock symbol {{StockChart.Ric}} does not exist

See Full Stock Page »

Canadian marijuana stocks went on a wild ride on Wednesday as a number of the companies’ shares soared in the morning and were later halted after massive spikes in trading.

The country’s publicly-traded marijuana companies, including Canopy Growth Corp (CGC.TO), Aurora Cannabis Inc (ACB.V), Mettrum Health Corp (MT.V), Aphria Inc (APH.V), OrganiGram Holdings Inc (OGI.V), and Supreme Pharmaceuticals Inc were all halted for brief periods.

Smith Falls, Ont.-based Canopy was halted five separate times. Its stock surged as high as 33 per cent, dropped as low as 27 per cent and ended down 15.24 per cent to close at $11.40 per share. More than 24 million shares of Canopy changed hands on Wednesday.

In its earnings report earlier this week, Canopy -- Canada's largest producer of medical marijuana -- reported that revenue rose to $8.5 million, a 245 per cent increase over the same period last year.

While Aurora was the only producer to remain in positive territory -- closing up 11.79 per cent to $2.94 a share -- Mettrum ended down 11.76 per cent to $6 a share, Aphria fell 8.41 per cent to $5.77 and Organigram declined nearly 11 per cent to $3.42. 

The Investment Industry Regulatory Organization of Canada issued the halt and resumption notices, citing “single-stock circuit breaker” as the reason.

The financial markets regulator's single-stock circuit breaker is usually triggered when securities experience price changes of at least 10 per cent.

“IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market,” IIROC said in a statement.

Marijuana stocks have been on a tear since last week, after California, Maine, Massachusetts and Nevada voted to approve recreational use of the drug. The four states join Alaska, Colorado, Oregon, Washington, and Washington, D.C., which already have similar laws in place.